Fernández-Lázaro, D.; Iglesias-Lázaro, M.; Garrosa, E.; RodrÃguez-GarcÃa, S.; Jerves Donoso, D.; Gutiérrez-Abejón, E.; Jorge-Finnigan, C.
Impact of Innovative Treatment Using Biological Drugs for the Modulation of Diffuse Cutaneous Systemic Sclerosis: A Systematic Review. Medicina 2023, 59, 247.
https://doi.org/10.3390/medicina59020247
AMA Style
Fernández-Lázaro D, Iglesias-Lázaro M, Garrosa E, RodrÃguez-GarcÃa S, Jerves Donoso D, Gutiérrez-Abejón E, Jorge-Finnigan C.
Impact of Innovative Treatment Using Biological Drugs for the Modulation of Diffuse Cutaneous Systemic Sclerosis: A Systematic Review. Medicina. 2023; 59(2):247.
https://doi.org/10.3390/medicina59020247
Chicago/Turabian Style
Fernández-Lázaro, Diego, MarÃa Iglesias-Lázaro, Evelina Garrosa, Saray RodrÃguez-GarcÃa, David Jerves Donoso, Eduardo Gutiérrez-Abejón, and Conrado Jorge-Finnigan.
2023. "Impact of Innovative Treatment Using Biological Drugs for the Modulation of Diffuse Cutaneous Systemic Sclerosis: A Systematic Review" Medicina 59, no. 2: 247.
https://doi.org/10.3390/medicina59020247
APA Style
Fernández-Lázaro, D., Iglesias-Lázaro, M., Garrosa, E., RodrÃguez-GarcÃa, S., Jerves Donoso, D., Gutiérrez-Abejón, E., & Jorge-Finnigan, C.
(2023). Impact of Innovative Treatment Using Biological Drugs for the Modulation of Diffuse Cutaneous Systemic Sclerosis: A Systematic Review. Medicina, 59(2), 247.
https://doi.org/10.3390/medicina59020247
